Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer

Gene Therapy

Volumn 16, Issue 5, 2009, Pages 629-634

  Hedman, M ^a   Muona, K ^a   Hedman, A ^a   Kivela A ^a   Syvanne M ^b   Eranen J ^a   Rantala, A ^a   Stjernvall, J ^b   Nieminen, M S ^b   Hartikainen, J ^a   Yla Herttuala S ^a,c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; LIPOSOME; PLACEBO; PLASMID VECTOR; VASCULOTROPIN 165;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ANGIOGENIC GENE THERAPY; ARTICLE; BACKACHE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; EXHAUSTION; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; OSTEOARTHRITIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

ADENOVIRIDAE; ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; CORONARY DISEASE; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LIPOSOMES; MIDDLE AGED; PLASMIDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ADENOVIRIDAE;

EID: 67349112757     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2009.4     Document Type: Article

References (21)

1. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K et al Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-1123.
2. Hedman M, Hartikainen J, Syvänne M, Stjernvall J, Hedman A, Kivelä A et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107: 2677-2683.
3. Laitinen M, Zachary I, Breier G, Pakkanen T, Häkkinen T, Luoma J et al. VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther 1997; 8: 1737-1744.
4. Mäkinen K, Manninen H, Hedman M, Matsi P, Mussalo H, Alhava E et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: A randomized, placebo-controlled, double-blinded phase II study. Mol Ther 2002; 6: 127-133.
5. Ylä-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000; 335: 213-222.
6. Ylä-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694-701.
7. Ylä-Herttuala S, Rissanen T, Vajanto I, Hartikainen J. Vascular endothelial growth factors: Biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 2007; 49: 1015-1026.
8. Gaffney MM, Hynes SO, Barry F, O'Brien T. Cardiovascular gene therapy: current status and therapeutic potential. Br J Pharmacol 2007; 152: 175-188.
9. Laitinen M, Mäkinen K, Manninen H, Matsi P, Kossila M, Agrawal R et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischaemia. Hum Gene Ther 1998; 9: 1481-1486.
10. Kusumanto YH, van Weel V, Mulder NH, Smit AJ, van Dungen JJ, Hooymans JM et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: A double-blind randomized trial. Hum Gene Ther 2006; 17: 683-691.
11. Laitinen M, Pakkanen T, Donetti E, Baetta R, Luoma J, Viita H et al Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses. Hum Gene Ther 1998; 8: 1645-1650.
12. Puumalainen AM, Vapalahti M, Agrawal RS, Kossila RS, Laukkanen J, Lehtolainen P et al. Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum Gene Ther 1998; 9: 1769-1774.
13. Wirth T, Hedman M, Mäkinen K, Manninen H, Immonen A, Vapalahti M et al. Safety profile of plasmid/liposomes and virus vectors in clinical gene therapy. Curr Drug Saf 2006; 1: 253-257.
14. Alton EW, Stern M, Farley R, Jaffe A, Chadwick SL, Phillips J et al Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: A double-blind placebo-controlled trial. Lancet 1999; 353: 947-954.
15. Shayakhmetov DM, Gaggar A, Ni S, Li Z-Y, Lieber A. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 2005; 79: 7478-7491.
16. Grines CL, Watkins MW, Mahmarian JJ, Iskandrian AE, Rade JJ, Marrot P et al. Angiogene GENe Therapy (AGENT-2) Study Group. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol 2003; 42: 1339-1347.
17. Henry TD, Grines CL, Watkins MW, Dib N, Barbeau G, Moreadith R et al Effects of Ad5FGF-4 in patients with angina: An analysis of pooled data from the AGENT-3 and AGENT-4 trials. J Am Coll Cardiol 2007; 50: 1038-1046.
18. Kastrup J, Jørgensen E, Rück A, Tägil K, Glogar D, Ruzyllo W, et al., The Euroinject One Group. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris: A randomized double-blind placebo-controlled study: The Euroinject One Trial. J Am Coll Cardiol 2005; 45: 982-988.
19. Stewart DJ, Hilton JD, Arnold JM, Gregoire J, Rivard A, Archer SL et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: A phase 2 randomized, controlled trial of AdVEGF(121) versus maximum medical treatment. Gene Therapy 2006; 13: 1503-1511.
20. Leppänen P, Koota S, Kholová I, Koponen J, Fieber C, Eriksson U et al. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice. Circulation 2005; 112: 1347-1352.
21. ΔNΔC gene transfer induces transmural angiogenesis in porcine heart. Circulation 2004; 109: 1029-1035.